Women’s health ingredients help US brands build products for menopause comfort, everyday energy and women’s nutritional needs across life stages. This guide explains how formulators can evaluate these ingredients by format fit, dose transparency and documentation — using structure/function language, not disease claims — and points to the routes Nutrition BioTech supports for this category, including S-Equol as a supplied ingredient route and stocked low-dose iron and energy-support companions.
How to evaluate a women’s health ingredient for a finished format
When you evaluate a women’s health ingredient, four practical questions matter more than marketing language: does the form fit your delivery system (capsule, gummy, stick or tablet); is the active dose transparent and appropriate for a general-wellness, structure/function positioning; can the supplier document identity, purity and stability; and does the claim boundary keep your regulatory team comfortable? Nutrition BioTech supplies each route with that evaluation in mind.
Ingredient routes for this category
- S-Equol (menopause positioning) — a soy isoflavone metabolite positioned for capsule and tablet formats and framed with structure/function language for menopause comfort and everyday balance, not disease or hormone-treatment claims. S-Equol is available from Nutrition BioTech as a supplied ingredient route. Confirm specification, availability and lead time with us for your project before you fix a unit dose around it.
- Women’s iron & everyday-energy companion — a route supplying a low-dose iron contribution (a fraction of daily needs), positioned for general women’s wellness and energy support — not as an anemia treatment or a prenatal product.
- Folate form selection — L-5-MTHF is supplied as the calcium or the glucosamine salt, and the two differ in free-acid-equivalent folate per unit mass. Our L-5-MTHF vs folic acid comparison covers salt basis, [6S] diastereomer specification, stability and US label units; the material itself sits at L-5-Methyltetrahydrofolate.
- Browse the full ingredient catalog or review our quality & certifications.
Each route is documented so your quality and regulatory teams can review it before sampling.
Identity and standardisation: what to specify on a COA for women’s health ingredients
Women’s health ingredients are specified, not marketed, on a certificate of analysis. The fastest way to compare quotes and catch substitution is to anchor every line item to a registry identity — CAS number, molecular formula and molecular weight — and to state the assay basis (salt or free acid, enantiomer, isomer) that each percentage refers to. Every identifier in the table below is registry-verifiable.
| Substance | CAS number | Molecular formula | Molecular weight (g/mol) | Specification note |
|---|---|---|---|---|
| S-Equol | 531-95-3 | C₁₅H₁₄O₃ | 242.27 | CAS designates the S-enantiomer; COA should state enantiomeric identity |
| Myo-inositol | 87-89-8 | C₆H₁₂O₆ | 180.16 | Isomer-specific identity required; formula alone cannot distinguish isomers |
| D-chiro-inositol | 643-12-9 | C₆H₁₂O₆ | 180.16 | Same formula and MW as myo-inositol; different CAS; chiral identity method |
| L-5-MTHF free acid (levomefolic acid) | 31690-09-2 | C₂₀H₂₅N₇O₆ | 459.5 | The common denominator for folate-form comparisons |
| Levomefolate calcium (L-5-MTHF-Ca) | 151533-22-1 | C₂₀H₂₃CaN₇O₆ | 497.5 | ≈92.4% free-acid equivalents by molecular weight |
| Folic acid | 59-30-3 | C₁₉H₁₉N₇O₆ | 441.4 | A different molecule from L-5-MTHF, not an assay-basis variant |
| Ferrous bisglycinate | 20150-34-9 | C₄H₈FeN₂O₄ | 203.96 | ≈27.4% elemental iron by molecular arithmetic |
Salt-to-free-acid basis. Levomefolate calcium (MW 497.5) converts to L-5-MTHF free-acid equivalents by the ratio 459.5 ÷ 497.5 = 0.924 — so a lot assayed at 98% as the calcium salt delivers about 0.905 g of free-acid equivalents per gram. Two quotes that both say “98%” can therefore describe different deliverable quantities; our guide on how to compare ingredient quotes walks through the same arithmetic for other salt forms.
Chelate arithmetic. Ferrous bisglycinate (C₄H₈FeN₂O₄, MW 203.96) contains one iron atom (55.845), which works out to ≈27.4% elemental iron — about 274 mg iron per gram of the pure chelate. An elemental-iron figure materially below that on a COA usually indicates a blended or carrier-diluted material; that is a specification question to raise before comparing prices, not necessarily a defect.
Isomer and enantiomer boundaries. Myo-inositol and D-chiro-inositol share the formula C₆H₁₂O₆ and MW 180.16, so formula and molecular weight cannot distinguish them — identity must come from an isomer-specific method such as optical rotation or a resolving chromatographic method. Equol is likewise enantiomer-specific: CAS 531-95-3 designates (S)-equol, and a COA should confirm the stereodescriptor rather than stating “equol” alone. Our guide on how to verify a supplier COA covers which identity tests to ask for.
Frequently asked questions
What does a women’s health positioning mean for a formulator?
It means building products for menopause comfort, everyday energy and women’s nutritional needs using structure/function language — supporting comfort, balance and energy — without disease, treatment or pregnancy-safety claims. We help you keep the positioning claim-safe while matching the ingredient form to your format.
How is S-Equol positioned for a menopause product?
S-Equol is a soy isoflavone metabolite positioned for capsule and tablet formats and positioned with structure/function language for menopause comfort and everyday balance. We share specification and format notes, and we do not make disease or hormone-treatment claims. S-Equol is available from Nutrition BioTech as a supplied ingredient route. Confirm specification, availability and lead time with us for your project before you fix a unit dose around it.
How should we handle iron and energy claims for a women’s product?
Our women’s iron and everyday-energy companion supplies a low-dose iron contribution — a fraction of daily needs — and is positioned for general women’s wellness and energy support, not as an anemia treatment or a prenatal product. We provide the dose and documentation so your team can position it accurately.
What documentation do you provide?
For every route we can provide a Certificate of Analysis (COA), specification sheet, allergen and GMO statements, and stability and method information on request, so your quality and regulatory teams can review identity, purity and consistency before sampling.
Ready to evaluate a women’s health route for your next format?
Request a sample, COA or spec →
How do I convert a levomefolate calcium quote into L-5-MTHF free-acid equivalents?
Multiply by the molecular-weight ratio 459.5 ÷ 497.5 ≈ 0.924. A lot assayed at 98% as the calcium salt (CAS 151533-22-1) delivers about 0.905 g of L-5-MTHF free-acid equivalents (CAS 31690-09-2) per gram. When a folic acid quote (CAS 59-30-3) is in the same comparison, confirm which molecule and which assay basis each percentage refers to before comparing prices.
What identity markers should a COA show for S-Equol?
CAS 531-95-3 designates the S-enantiomer specifically. Beyond the molecular formula C15H14O3 and molecular weight 242.27, the COA should state enantiomeric identity by a chiral method, because “equol” without a stereodescriptor does not confirm the S-form. Supporting documentation is available under buyer review.
Why do myo-inositol and D-chiro-inositol need isomer-specific identity testing?
Both share the formula C6H12O6 and molecular weight 180.16, so formula and molecular weight cannot tell them apart. Their CAS numbers differ (87-89-8 vs 643-12-9), and a COA should confirm identity by an isomer-specific method such as optical rotation or a resolving chromatographic method, and state the isomer ratio for any blended material.